Literature DB >> 24188491

Role of inflammatory cells and toll-like receptors in atherosclerosis.

Anusha N Seneviratne, Claudia Monaco1.   

Abstract

The primary cause of cerebrovascular disease is atherosclerosis, to which many factors contribute. At first many saw atherosclerosis as a lipid-driven disease. Recently inflammation has appeared as a significant factor in the disease. Innate immune cells, for example monocytes and macrophages, are important in atherosclerosis. Toll-like receptors (TLRs) are the best-studied family of receptor in the immune system. TLR engagement with their ligands stimulates pro-inflammatory cytokine production and foam cell generation. Recently certain TLRs have shown a protective role in atherosclerosis. In this review, we analyse innate immunity, focusing on TLR signalling and macrophages, in atherosclerosis and acute cerebrovascular complications, and thereby discuss their potential as therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24188491     DOI: 10.2174/15701611113116660160

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  8 in total

1.  Natural Biflavonoids Modulate Macrophage-Oxidized LDL Interaction In Vitro and Promote Atheroprotection In Vivo.

Authors:  Jorge H Tabares-Guevara; Oscar J Lara-Guzmán; Julian A Londoño-Londoño; Jelver A Sierra; Yudy M León-Varela; Rafael M Álvarez-Quintero; Edison J Osorio; José R Ramirez-Pineda
Journal:  Front Immunol       Date:  2017-08-04       Impact factor: 7.561

2.  Interleukin‑37 is increased in peripheral blood mononuclear cells of coronary heart disease patients and inhibits the inflammatory reaction.

Authors:  Huimin Li; Chen Shen; Bingni Chen; Jing Du; Bin Peng; Wei Wang; Fanwu Chi; Xiaoqiang Dong; Zhong Huang; Chao Yang
Journal:  Mol Med Rep       Date:  2019-11-06       Impact factor: 2.952

Review 3.  Atherosclerosis and Coenzyme Q10.

Authors:  Juan M Suárez-Rivero; Carmen J Pastor-Maldonado; Mario de la Mata; Marina Villanueva-Paz; Suleva Povea-Cabello; Mónica Álvarez-Córdoba; Irene Villalón-García; Alejandra Suárez-Carrillo; Marta Talaverón-Rey; Manuel Munuera; José A Sánchez-Alcázar
Journal:  Int J Mol Sci       Date:  2019-10-20       Impact factor: 5.923

4.  Identification and functional analysis of a biflavone as a novel inhibitor of transient receptor potential vanilloid 4-dependent atherogenic processes.

Authors:  Mazen O Alharbi; Bidisha Dutta; Rishov Goswami; Shweta Sharma; Kai Y Lei; Shaik O Rahaman
Journal:  Sci Rep       Date:  2021-04-14       Impact factor: 4.379

5.  Association Between Immunoglobulin G N-glycosylation and Vascular Cognitive Impairment in a Sample With Atherosclerosis: A Case-Control Study.

Authors:  Meng Wang; Xueyu Chen; Zhaoyang Tang; Wenran Zhang; Haifeng Hou; Xiangfu Sun; Yuqing Shi; Xinxia Lu; Peirui Li; Long Ji; Guoyong Ding; Dong Li
Journal:  Front Aging Neurosci       Date:  2022-02-10       Impact factor: 5.750

6.  Salvianolic acid B attenuates the inflammatory response in atherosclerosis by regulating MAPKs/ NF-κB signaling pathways in LDLR-/- mice and RAW264.7 cells.

Authors:  Yifan Zhang; Xiaoteng Feng; Min Du; Jie Ding; Ping Liu
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.298

7.  Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation.

Authors:  Wei Wang; Sha-Sha Li; Xin-Feng Xu; Chan Yang; Xiao-Ge Niu; Shu-Xian Yin; Xiao-Yan Pan; Wei Xu; Guo-Dong Hu; Chan Wang; Shu-Wen Liu
Journal:  Acta Pharmacol Sin       Date:  2021-07-15       Impact factor: 6.150

8.  Roadmap Consensus on Carotid Artery Plaque Imaging and Impact on Therapy Strategies and Guidelines: An International, Multispecialty, Expert Review and Position Statement.

Authors:  L Saba; W Brinjikji; J D Spence; M Wintermark; M Castillo; G J de Borst; Q Yang; C Yuan; A Buckler; M Edjlali; T Saam; D Saloner; B K Lal; D Capodanno; J Sun; N Balu; R Naylor; A V D Lugt; B A Wasserman; M E Kooi; J Wardlaw; J Gillard; G Lanzino; U Hedin; D Mikulis; A Gupta; J K DeMarco; C Hess; J V Goethem; T Hatsukami; P Rothwell; M M Brown; A R Moody
Journal:  AJNR Am J Neuroradiol       Date:  2021-07-29       Impact factor: 4.966

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.